A Case of Sorafenib-induced DRESS Syndrome in Hepatocelluar Carcinoma / 대한소화기학회지
The Korean Journal of Gastroenterology
;
: 337-340, 2016.
Artículo
en Inglés
| WPRIM
| ID: wpr-91783
ABSTRACT
Sorafenib is currently the only targeted therapy available for advanced stage hepatocellular carcinoma (HCC). Cutaneous adverse events associated with sorafenib treatment include hand-foot skin reaction, but there has been no report of drug reaction (or rash) with eosinophilia and systemic symptoms (DRESS) syndrome. Here, we report a case of 72-year-old man with HCC and alcoholic liver cirrhosis who developed skin eruptions, fever, eosinophilia, and deteriorated hepatic and renal function under sorafenib treatment. He has since successfully recovered with conservative care.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Piel
/
Carcinoma Hepatocelular
/
Eosinofilia
/
Fiebre
/
Síndrome de Hipersensibilidad a Medicamentos
/
Cirrosis Hepática Alcohólica
Límite:
Anciano
/
Humanos
Idioma:
Inglés
Revista:
The Korean Journal of Gastroenterology
Año:
2016
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS